Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Cheng-Di Liu"'
Autor:
Nan-nan Liu, Guodong Ma, Guanhua Du, Ke-xin Wang, Li Gao, Haiguang Yang, Cheng-di Liu, Xue-Mei Qin, Linglei Kong
Publikováno v:
Acta Pharmacol Sin
Hemorrhagic transformation (HT) is a common serious complication of stroke after thrombolysis treatment, which limits the clinical use of tissue plasminogen activator (t-PA). Since early diagnosis and treatment for HT is important to improve the prog
Publikováno v:
Acta Pharmacol Sin
Stroke is an acute cerebrovascular disease caused by ruptured or blocked blood vessels. For the prevention of ischemic stroke, the coagulation state of blood and cerebrovascular protection should be considered. Our previous study has shown that salvi
Autor:
Sen Zhang, De-wen Kong, Guo-dong Ma, Cheng-di Liu, Yu-jiao Yang, Shan Liu, Nan Jiang, Zi-rong Pan, Wen Zhang, Ling-lei Kong, Guan-hua Du
Publikováno v:
Acta pharmacologica Sinica. 43(9)
Stroke is the major cause of death and disability worldwide. Most stroke patients who survive in the acute phase of ischemia display various extents of neurological deficits. In order to improve the prognosis of ischemic stroke, promoting endogenous
Publikováno v:
Pharmacological Research. 170:105737
At present, the prevention and control of cardiovascular diseases (CAVDs) has made initial advancements, although the prevention and control of cerebrovascular diseases (CEVDs) has not yet achieved the desired progress. In this paper, we review the p
Autor:
Yujiao Yang, Shan Liu, Guangyi Wei, Guodong Ma, Cheng-di Liu, Guanhua Du, Linglei Kong, Nan-nan Liu
Publikováno v:
Pharmacological Research. 169:105650
Stroke is one of the leading causes of death worldwide. Hemorrhagic transformation (HT) is a common serious complication of ischemic stroke (IS) and is related to poor prognosis. Hyperglycemia after stroke is associated with the occurrence of HT and
Publikováno v:
The FASEB Journal. 33
Publikováno v:
Acta Pharmacologica Sinica. 42:1014-1014
Autor:
Jing Ai, Yang-Yang Hao, Yan Yan, Huan Ren, De-Kang Zong, Wenjing Xing, Lin-Lin Sun, Qin Wang, Shuang-Chao Pei, Meng Mao, Cheng-Di Liu, Mei-Ling Yan
Publikováno v:
Neurobiology of Aging. 45:76-87
Reduction of protein phosphatase-2A (PP2A) activity is a common clinical feature of Alzheimer's disease and vascular dementia. In this study, we observed that chronic brain hypoperfusion induced by bilateral common carotid artery occlusion of rats le
Autor:
Qin Wang, X.-H. Kang, Ning Wang, Cheng-Di Liu, Jing Ai, Tong Liu, De-Kang Zong, Ji-Chao Ma, Lihua Sun, Shuang-Chao Pei, Xudong Wang, Xinren Chen, Ming-Jing Duan, Mei-Ling Yan
Publikováno v:
Neuroscience. 299:66-78
Large cohort studies have revealed a close relationship between cognitive impairment and cardiovascular diseases, although the mechanism underlying this relationship remains incompletely understood. In this study, using a transgenic (Tg) mouse model
Autor:
Ya-Nan Bao, Qing-Xin Chen, Jing Ai, Mei-Ling Yan, Xiaolin Su, Tao Ban, Cheng-Di Liu, Xue-Mei Jiang, De-Kang Zong, Xu Wang, Lihua Sun, Lin-Lin Sun, Xue-Ling Hu, Shuang-Chao Pei, Lin-Jing Zhao
Publikováno v:
Journal of neurochemistry. 134(6)
Chronic brain hypoperfusion (CBH) is a common clinical feature of Alzheimer's disease and vascular dementia, but the underlying molecular mechanism is unclear. Our previous study reported that the down-regulation of microRNA-195 (miR-195) promotes am